Five things for pharma marketers to know: Monday, January 9, 2023
Pfizer discusses license for generic Paxlovid treatment with China; AbbVie spends $30 million upfront for Immunome partnership to bolster antibody research.
Source: mmm-online.com
Page 9 - Discovery Engine News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Discovery Engine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Discovery Engine Today - Breaking & Trending Today
AbbVie, Immunome Collaborate To Discover Multiple Novel Oncology Targets
WASHINGTON (dpa-AFX) - AbbVie (ABBV) and Immunome Inc. (IMNM) have collaborated to discover up to 10 novel antibody-target pairs arising from three specified tumor types using Immunome's Discovery
Source: finanznachrichten.de
AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets
/PRNewswire/ -- AbbVie (NYSE: ABBV) and Immunome, Inc. (Nasdaq: IMNM), a clinical-stage biopharmaceutical company that utilizes its human memory B cell...
Source: prnewswire.com
AbbVie Taps Immunome to Discover as Many as 10 Oncology Targets
AbbVie announced a collaboration with clinical-stage biopharma company Immunome to discover as many as 10 novel oncology antibody-target pairs.
Source: insideprecisionmedicine.com
Arvinas Announces Changes to its Board of Directors
NEW HAVEN, Conn., Dec. 16, 2022 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs...
Source: globenewswire.com